1-2 of 2
Suliman Al-Fayoumi, PhD MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Kinase Profile of Pacritinib, a Non-Myelosuppressive JAK2 Kinase Inhibitor in Phase 3 Development in Primary and Post ET/PV Myelofibrosis

Jack Singer, MD, Suliman Al-Fayoumi, PhD MBA, Haiching Ma, Rami S Komrokji, MD, Ruben Mesa, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1874.
https://doi.org/10.1182/blood.V124.21.1874.1874
Published: 2014
Journal Articles

Exposure-Response Analysis For Pacritinib (SB1518), a Novel Oral JAK2/FLT3 Inhibitor, In Patients With Myelofibrosis

Suliman Al-Fayoumi, PhD, MBA, Lixia Wang, PhD, Hanbin Li, PhD, Russ Wada, PhD, James P. Dean, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4080.
https://doi.org/10.1182/blood.V122.21.4080.4080
Published: 2013